{"chunk_type":"transcript_chunk","text":"# ECG Arrhythmia Framework: Supraventricular to Ventricular\n## Supraventricular patterns\n- PSVT: narrow regular tachycardia, AV nodal re-entry 맥락에서 vagal maneuver/adenosine 기반 접근.\n- Atrial fibrillation: irregularly irregular rhythm, rate-control vs rhythm-control을 증상/상황 기반으로 선택.\n- MAT: irregular rhythm + ≥3 P-wave morphologies, COPD/폐질환 맥락을 반드시 확인.\n\n## Ventricular emergency patterns\n- VT는 안정/불안정 여부가 치료 우선순위를 결정.\n- Torsades는 prolonged QT 기반 polymorphic VT로 magnesium이 1차.\n- wide-complex tachycardia에서는 capture/fusion beat 단서가 VT 진단에 유용.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-237","focus_area":"ECG Arrhythmia Framework","tags":["usmle-step2","cardiology","ecg","arrhythmia","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Bradycardia and AV Block Management Table\n## Symptomatic bradycardia algorithm\n- 불안정 서맥은 atropine 우선 후 pacing escalation.\n- 무증상 생리적 서맥은 치료보다 관찰이 원칙.\n\n## AV block table\n| 유형 | ECG 핵심 | 위험도/치료 |\n| --- | --- | --- |\n| 1도 AV block | PR 연장, 전도는 유지 | 대개 관찰 |\n| 2도 Mobitz I | PR 점차 연장 후 beat drop | 대개 안정, 원인 교정 |\n| 2도 Mobitz II | PR 일정 + 갑작스런 QRS 탈락 | 고위험, pacemaker 고려 |\n| 3도 complete block | AV dissociation | 응급 pacing/permanent pacemaker |\n\n## Sick sinus syndrome\n- brady-tachy 변동이 반복되면 pacing + 동반 빈맥치료를 병행.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-257","focus_area":"Bradycardia and AV Blocks","tags":["usmle-step2","cardiology","bradycardia","av-block","table","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Heart Failure Framework and Diagnostic Specificity\n## HF phenotypes\n- HFrEF(수축기), HFpEF(이완기), cor pulmonale(폐기원 우심부전), high-output HF를 구분.\n\n## Diagnostic clue table\n| 소견 | 해석 | 임상 가치 |\n| --- | --- | --- |\n| Dyspnea | 민감하지만 비특이 | 단독으로 확진 어려움 |\n| S3 gallop | volume overload 단서 | 특이도 높아 HF 지지 |\n| Orthopnea/PND | 좌심계 울혈 단서 | 특이도 상대적으로 높음 |\n| BNP/NT-proBNP | 심실 wall stress 반영 | 감별 및 추적에 유용 |\n\n## Severity framing\n- NYHA class는 예후/치료강도 설정에 직접 연결.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-1","focus_area":"Heart Failure Diagnosis Framework","tags":["usmle-step2","cardiology","heart-failure","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# HFrEF Prognosis, Acute Decompensation, and Chronic GDMT\n## Poor prognostic signals\n- 고NYHA, 저혈압, 고BNP, 전도이상, hyponatremia 등은 고위험군 단서.\n\n## Hyponatremia mechanism\n- 저박출 상태에서 neurohormonal activation(ADH 등)으로 희석성 저나트륨이 발생.\n\n## Acute decompensated HF\n- oxygenation, preload/afterload 조절, 이뇨 전략, 체위/환기 보조를 단계적으로 적용.\n\n## Chronic HFrEF pillars\n- ARNI/ACEi/ARB + evidence-based beta-blocker + MRA + SGLT2 inhibitor.\n- 적응증 충족 시 ICD/CRT 같은 기기치료를 고려.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-21","focus_area":"HFrEF Acute and Chronic Management","tags":["usmle-step2","cardiology","hfrEF","acute-care","gdmt"]}
{"chunk_type":"transcript_chunk","text":"# HFpEF, Cor Pulmonale, and High-output HF\n## HFpEF\n- hypertensive/aging/obesity background에서 diastolic stiffness가 중심.\n- volume/BP control과 동반질환 교정이 핵심.\n\n## Cor pulmonale\n- chronic lung disease로 인한 pulmonary HTN -> RV failure 패턴(JVD, edema, hepatomegaly).\n\n## High-output HF\n- AV fistula, severe anemia, thyrotoxicosis, beriberi 등 demand 과다 상황에서 발생.\n- EF가 보존되어도 임상적 HF를 보일 수 있어 원인교정이 치료의 중심.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-41","focus_area":"HFpEF Cor Pulmonale High-output HF","tags":["usmle-step2","cardiology","hfpef","cor-pulmonale","high-output-hf"]}
{"chunk_type":"recap_summary","text":"# Heart Failure Rapid Recap + Peripheral Vascular Disease Entry\n## HF recap\n1. HF 진단은 증상 + 특이 신체소견 + biomarker/echo 통합으로 한다.\n2. HFrEF는 질병완화보다 생존이득 약물의 조기 조합이 중요.\n3. hyponatremia는 중증도 악화 신호.\n4. cor pulmonale/high-output HF는 원인 축이 다르므로 구분 치료가 필요.\n\n## Transition\n- 다음 블록은 PAD/venous disease를 전신 심혈관 위험 관점에서 연결한다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-53","focus_area":"Heart Failure Recap and PVD Entry","tags":["usmle-step2","cardiology","heart-failure","recap"]}
{"chunk_type":"transcript_chunk","text":"# Peripheral Artery Disease: ABI Trap and Global Risk Strategy\n## PAD big picture\n- 하지 증상은 전신 동맥경화 burden의 말초 표현으로 본다.\n\n## ABI interpretation\n- ABI <0.9는 PAD 시사.\n- ABI가 과도하게 높으면(비압박성 석회화 혈관) 위음성 가능성이 있어 대체 검사 필요.\n\n## Treatment priorities\n- limb symptom 관리와 별개로 antiplatelet/statin/smoking cessation/exercise로 MACE를 줄이는 것이 핵심.\n- supervised exercise는 collateral development와 기능회복에 효과적.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-63","focus_area":"PAD Diagnostic and Treatment Strategy","tags":["usmle-step2","cardiology","pad","abi","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Venous Disease and Anaphylactic Shock Core\n## Venous insufficiency framework\n- dependent edema/skin change/ulcer pattern을 동맥성 허혈과 구분.\n- compression, elevation, 국소 피부관리 등 보존적 치료가 기반.\n\n## Anaphylactic shock\n- 1차 치료는 IM epinephrine.\n- airway/breathing/circulation 동시 안정화, 필요 시 반복 epi/수액/보조약제 사용.\n- 피부소견 + 호흡기/혈압 징후를 함께 확인해 지연을 줄인다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-83","focus_area":"Venous Disease and Anaphylaxis","tags":["usmle-step2","cardiology","venous-insufficiency","anaphylaxis"]}
{"chunk_type":"transcript_chunk","text":"# Hemorrhagic Shock and Damage Control Resuscitation\n## Modern trauma resuscitation\n- 대량 crystalloid 회피, 조기 혈액제제 중심 resuscitation이 원칙.\n- 응고장애/저체온/산증 악순환(triad)을 끊는 전략이 핵심.\n\n## Key actions\n- balanced transfusion strategy(대량출혈 프로토콜).\n- TXA 적절 시점 투여 고려.\n- source control 전까지 permissive hypotension을 적용하되 TBI 동반 시 목표혈압 전략을 수정.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-103","focus_area":"Hemorrhagic Shock DCR","tags":["usmle-step2","critical-care","hemorrhagic-shock","trauma","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Obstructive vs Cardiogenic Shock Hemodynamics\n## Obstructive shock\n- PE, tension pneumothorax, tamponade 등 기계적 유출입 장애.\n- scenario별 bedside clue로 빠르게 원인 배제/확인.\n\n## Cardiogenic shock\n- pump failure로 폐울혈/저관류가 동반.\n\n## Hemodynamic contrast\n- filling pressure/PCWP와 lung exam(wet vs relatively clear)을 통합하면 분류 정확도가 높아진다.\n- 분류에 따라 처치(원인 제거 vs inotrope/reperfusion)가 달라진다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-123","focus_area":"Obstructive vs Cardiogenic Shock","tags":["usmle-step2","critical-care","obstructive-shock","cardiogenic-shock","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Shock Rapid Fire Recap Table\n| 쇼크 유형 | 핵심 기전 | 주요 단서 | 우선 처치 |\n| --- | --- | --- | --- |\n| Anaphylactic | distributive + capillary leak | skin/airway/hypotension | IM epinephrine + airway + fluids |\n| Hemorrhagic | intravascular volume loss | trauma/bleeding markers | balanced transfusion + source control |\n| Obstructive | mechanical block | JVD/특정 원인 단서 | cause-specific decompression/removal |\n| Cardiogenic | pump failure | low output + pulmonary congestion | inotrope/reperfusion/support |\n\n- permissive hypotension은 selected trauma 상황에서만 적용하며 예외(TBI)를 기억.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-139","focus_area":"Shock Rapid Recap","tags":["usmle-step2","critical-care","shock","recap","table"]}
{"chunk_type":"transcript_chunk","text":"# Pericarditis, Constrictive Pericarditis, Myocarditis, Tamponade\n## Acute pericarditis\n- pleuritic chest pain + positional relief(leaning forward)가 핵심 단서.\n\n## Constrictive pericarditis\n- chronic rigid pericardium으로 우심부전 양상과 pericardial knock를 보일 수 있다.\n\n## Myocarditis\n- viral prodrome 뒤 새로 발생한 LV dysfunction/arrhythmia를 의심.\n\n## Cardiac tamponade\n- hypotension/JVD/muffled heart sound + pulsus paradoxus.\n- hemodynamic collapse에서는 지체 없는 pericardial drainage가 생명구조.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-149","focus_area":"Pericardial and Myocardial Inflammation","tags":["usmle-step2","cardiology","pericarditis","myocarditis","tamponade"]}
{"chunk_type":"transcript_chunk","text":"# Myocarditis and Tamponade Hemodynamic Pearls\n- myocarditis는 \"젊은 환자 + 감염 후 + 설명 안 되는 심부전\" 조합에서 진단 가치를 갖는다.\n- tamponade는 diastolic filling 제한으로 chamber pressure equalization 소견이 나올 수 있다.\n- electrical alternans, enlarged cardiac silhouette 등 영상/ECG 단서를 clinical picture와 결합한다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-169","focus_area":"Myocarditis and Tamponade Pearls","tags":["usmle-step2","cardiology","tamponade","myocarditis","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Cardio Misc Integration + Final Structural Signal Recap\n## Misc integration highlights\n- vasovagal syncope는 reflex-mediated bradycardia/vasodilation으로 설명.\n- 운동 중 실신은 구조적/전기적 치명 원인(예: anomalous coronary, HCM)을 우선 배제.\n- stent thrombosis/valve thrombosis는 항혈전 유지 실패와 직결.\n- recurrent epistaxis + AVM 맥락에서는 HHT 관련 systemic risk(뇌농양/색전)를 연결.\n\n## Final recap\n- chest pain/실신/쇼크/심음을 개별 암기가 아니라 pressure-flow-structure 모델로 통합하면 Step 2 문제 해결력이 높아진다.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-180","focus_area":"Cardio Misc Integration Recap","tags":["usmle-step2","cardiology","misc","integration","recap"]}
